Last update:

Oncology & Cancer news

Oncology & Cancer

Radiopharmaceutical therapy offers promise for people with tough-to-treat meningioma brain tumors

A radiopharmaceutical therapy that has successfully extended progression-free survival for patients with neuroendocrine tumors shows early promise for delivering similar benefits to patients with difficult-to-treat meningioma, ...

Oncology & Cancer

What is CAR-T cell therapy? Oncologist explains

Roughly 635,000 new cases of lymphoma were diagnosed worldwide, according to the World Cancer Research Fund International's most recent report. Survival rates for aggressive lymphomas have improved significantly thanks to ...

Oncology & Cancer

Genetic mutations in HRAS, KRAS genes linked to childhood cancers

Hereditary changes in genes are often the cause of rare diseases. For example, disease-causing gene variants (PVs) in the HRAS gene cause Costello syndrome and PVs in the KRAS gene cause Noonan syndrome and cardio-facio-cutaneous ...

Oncology & Cancer

Treatment-free remission for chronic myeloid leukemia

Leukemias are cancers of the blood cells. Chronic myelogenous leukemia (CML) is an uncommon type of cancer of the bone marrow, which produces blood cells. "Myelogenous" refers to the type of blood cells this leukemia affects. ...

Oncology & Cancer

Saving time with AI-generated treatment plans for breast cancer

Drawing in the organs of individual breast cancer patients and then creating precise radiation plans appears to be faster by using artificial intelligence (AI) models. That way, it remains just as reliable and accurate. It ...

Oncology & Cancer

AI could predict breast cancer risk via 'zombie cells'

Women worldwide could see better treatment with new AI technology, which enables better detection of damaged cells and more precisely predicts the risk of getting breast cancer, shows new research from the University of Copenhagen.

Medical research

Promising drug combo targets aggressive bladder cancers

A new study in mice by researchers at the Herbert Irving Comprehensive Cancer Center (HICCC) has identified a promising drug combination for the treatment of muscle-invasive bladder cancer. Rosiglitazone plus trametinib worked ...

Oncology & Cancer

New study shows how cancer cells exploit the immune system

New research has discovered an important breakthrough that may overcome cancer treatment resistance. The immune system has a naturally occurring 'brake' that tells the body to silence key killer immune cells called CD8+ T-cells ...

Oncology & Cancer

Research team identifies a new way to treat prostate cancer

The American Cancer Society estimates there are nearly 300,000 new cases of prostate cancer every year in the U.S., and approximately one in eight men will be diagnosed with prostate cancer in their lifetime. Prostate cancer ...